Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity

Nature Communications

Volumn 6, Issue , 2015, Pages

  Peske, J David ^a   Thompson, Elizabeth D ^a,c   Gemta, Lelisa ^a   Baylis, Richard A ^a   Fu, Yang Xin ^b   Engelhard, Victor H ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN; LYMPHOTOXIN BETA RECEPTOR; SECONDARY LYMPHOID TISSUE CHEMOKINE; TUMOR ANTIGEN;

CYTOLOGY; GENE EXPRESSION; IMMUNITY; INFILTRATION; RODENT; SECRETION; TUMOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CHRONIC INFLAMMATION; CONTROLLED STUDY; FEMALE; FIBROBLAST; LUNG CARCINOMA; LYMPH NODE; LYMPH NODE LIKE VASCULATURE; LYMPHOID ORGAN; MELANOMA; MOUSE; NATURAL KILLER CELL; NONHUMAN; T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR VASCULARIZATION; ANIMAL; EXPERIMENTAL NEOPLASM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR MICROENVIRONMENT;

MURINAE;

ANIMALS; ANTIGENS, NEOPLASM; CHEMOKINE CCL21; FEMALE; GENE EXPRESSION REGULATION; IMMUNOGLOBULINS; LYMPHOTOXIN BETA RECEPTOR; MICE; MICE, KNOCKOUT; NEOPLASMS, EXPERIMENTAL; T-LYMPHOCYTES; TUMOR MICROENVIRONMENT;

EID: 84929379918     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms8114     Document Type: Article

References (63)

1. Girard, J.-P., Moussion, C. & Förster, R. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat. Rev. Immunol. 12, 762-773 (2012).
2. Aloisi, F. & Pujol-Borrell, R. Lymphoid neogenesis in chronic inflammatory diseases. Nat. Rev. Immunol. 6, 205-217 (2006).
3. Coppola, D. et al. Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling. Am. J. Pathol. 179, 37-45 (2011).
4. Martinet, L. et al. Human solid tumors contain high endothelial venules: association with T-and B-lymphocyte infiltration and favorable prognosis in breast cancer. Cancer Res. 71, 5678-5687 (2011).
5. Martinet, L. et al. High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes. Oncoimmunology 1, 829-839 (2012).
6. Messina, J. L. et al. 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? Sci. Rep. 2, 765 (2012).
7. Moussion, C. & Girard, J.-P. Dendritic cells control lymphocyte entry to lymph nodes through high endothelial venules. Nature 479, 542-546 (2011).
8. Browning, J. L. et al. Lymphotoxin-beta receptor signaling is required for the homeostatic control of HEV differentiation and function. Immunity 23, 539-550 (2005).
9. Gatumu, M. K. et al. Blockade of lymphotoxin-beta receptor signaling reduces aspects of Sjögren syndrome in salivary glands of non-obese diabetic mice. Arthritis Res. Ther. 11, R24 (2009).
10. Gräbner, R. et al. Lymphotoxin b receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J. Exp. Med. 206, 233-248 (2009).
11. Motallebzadeh, R. et al. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. FASEB J. 26, 51-62 (2012).
12. Rangel-Moreno, J. et al. The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat. Immunol. 12, 639-646 (2011).
13. GeurtsvanKessel, C. H. et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J. Exp. Med. 206, 2339-2349 (2009).
14. Halle, S. et al. Induced bronchus-associated lymphoid tissue serves as a general priming site for T cells and is maintained by dendritic cells. J. Exp. Med. 206, 2593-2601 (2009).
15. Cuff, C. A., Sacca, R. & Ruddle, N. H. Differential induction of adhesion molecule and chemokine expression by LTa3 and LTab in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development. J. Immunol. 162, 5965-5972 (1999).
16. Drayton, D. L., Ying, X., Lee, J., Lesslauer, W. & Ruddle, N. H. Ectopic LTab directs lymphoid organ neogenesis with concomitant expression of peripheral node addressin and a HEV-restricted sulfotransferase. J. Exp. Med. 197, 1153-1163 (2003).
17. Luther, S. A. et al. Differing activities of homeostatic chemokines CCL19, CCL21, and CXCL12 in lymphocyte and dendritic cell recruitment and lymphoid neogenesis. J. Immunol. 169, 424-433 (2002).
18. Marinkovic, T. et al. Interaction of mature CD3+ CD4+ T cells with dendritic cells triggers the development of tertiary lymphoid structures in the thyroid. J. Clin. Invest. 116, 2622-2632 (2006).
19. Kim, H.-J. et al. Establishment of early lymphoid organ infrastructure in transplanted tumors mediated by local production of Lymphotoxin a and in the combined absence of functional B and T cells. J. Immunol. 172, 4037-4047 (2004).
20. Schrama, D. et al. Targeting of Lymphotoxin - a to the tumor elicits an efficient immune response associated with induction of peripheral lymphoid-like tissue. Immunity 14, 111-121 (2001).
21. Shields, J. D., Kourtis, I. C., Tomei, A. A., Roberts, J. M. & Swartz, M. A. Induction of lymphoidlike stroma and immune escape by tumors that express the chemokine CCL21. Science 328, 749-752 (2010).
22. Martinet, L. et al. High endothelial venule blood vessels for tumor-infiltrating lymphocytes are associated with Lymphotoxin b-producing dendritic cells in human breast cancer. J. Immunol. 191, 2001-2008 (2013).
23. Hindley, J. P. et al. T-cell trafficking facilitated by high endothelial venules is required for tumor control after regulatory T-cell depletion. Cancer Res. 72, 5473-5482 (2012).
24. Thompson, E. D., Enriquez, H. L., Fu, Y.-X. & Engelhard, V. H. Tumor masses support naive T cell infiltration, activation, and differentiation into effectors. J. Exp. Med. 207, 1791-1804 (2010).
25. Yu, P. et al. Priming of naive T cells inside tumors leads to eradication of established tumors. Nat. Immunol. 5, 141-149 (2004).
26. Schrama, D. et al. Immunological tumor destruction in a murine melanoma model by targeted LTalpha independent of secondary lymphoid tissue. Cancer Immunol. Immunother. 57, 85-95 (2008).
27. Dankort, D. et al. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat. Genet. 41, 544-552 (2009).
28. Scimone, M. L., Aifantis, I., Apostolou, I., von Boehmer, H. & von Andrian, U. H. A multistep adhesion cascade for lymphoid progenitor cell homing to the thymus. PNAS 103, 7006-7011 (2006).
29. Walch, J. M. et al. Cognate antigen directs CD8+ T cell migration to vascularized transplants. J. Clin. Invest. 123, 2663-2671 (2013).
30. Palazón, A. et al. Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes. Cancer Res. 71, 801-811 (2011).
31. Sasaki, K. et al. Preferential expression of very late antigen-4 on type 1 CTL cells plays a critical role in trafficking into central nervous system tumors. Cancer Res. 67, 6451-6458 (2007).
32. Stein, J. V. et al. The CC chemokine thymus-derived chemotactic agent 4 (TCA-4, secondary lymphoid tissue chemokine, 6Ckine, exodus-2) triggers lymphocyte function-associated antigen 1-mediated arrest of rolling T lymphocytes in peripheral lymph node high endothelial venules. J. Exp. Med. 191, 61-76 (2000).
33. Ho, P.-C. et al. Immune-based antitumor effects of BRAF inhibitors rely on signaling by CD40L and IFNg. Cancer Res. 74, 3205-3217 (2014).
34. Damsky, W. E. et al. b-Catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell 20, 741-754 (2011).
35. Spranger, S., Bao, R. & Gajewski, T. Melanoma-intrinsic b-catenin signaling prevents T cell infiltration and anti-tumor immunity. J. Immunother. Cancer 2, O15 (2014).
36. Orr, M. T. & Lanier, L. L. Natural killer cell education and tolerance. Cell 142, 847-856 (2010).
37. Shinkai, Y. et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 68, 855-867 (1992).
38. Fletcher, A. L. et al. Lymph node fibroblastic reticular cells directly present peripheral tissue antigen under steady-state and inflammatory conditions. J. Exp. Med. 207, 689-697 (2010).
39. Brinkmann, V. et al. The immune modulator FTY720 targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453-21457 (2002).
40. Brinkmann, V. & Lynch, K. R. FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity. Curr. Opin. Immunol. 14, 569-575 (2002).
41. Sheasley-O'Neill, S. L., Brinkman, C. C., Ferguson, A. R., Dispenza, M. C. & Engelhard, V. H. Dendritic cell immunization route determines integrin expression and lymphoid and nonlymphoid tissue distribution of CD8 T cells. J. Immunol. 178, 1512-1522 (2007).
42. Brinkman, C. C., Sheasley-O'Neill, S. L., Ferguson, A. R. & Engelhard, V. H. Activated CD8 T cells redistribute to antigen-free lymph nodes and exhibit effector and memory characteristics. J. Immunol. 181, 1814-1824 (2008).
43. Cipponi, A. et al. Neogenesis of lymphoid structures and antibody responses occur in human melanoma metastases. Cancer Res. 72, 3997-4007 (2012).
44. Kumar, V. et al. Global lymphoid tissue remodeling during a viral infection is orchestrated by a B cell-lymphotoxin-dependent pathway. Blood 115, 4725-4733 (2010).
45. Liao, S. & Ruddle, N. H. Synchrony of high endothelial venules and lymphatic vessels revealed by immunization. J. Immunol. 177, 3369-3379 (2006).
46. Furtado, G. C. et al. Lymphotoxin beta receptor signaling is required for inflammatory lymphangiogenesis in the thyroid. Proc. Natl Acad. Sci. USA 104, 5026-5031 (2007).
47. Kratz, A., Campos-Neto, A., Hanson, M. S. & Ruddle, N. H. Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J. Exp. Med. 183, 1461-1472 (1996).
48. Sacca, R., Cuff, C. A., Lesslauer, W. & Ruddle, N. H. Differential activities of secreted lymphotoxin-a3 and membrane lymphotoxin-a1b2 in lymphotoxininduced inflammation: critical role of TNF receptor 1 signaling. J. Immunol. 160, 485-491 (1998).
49. Onder, L. et al. Endothelial cell-specific lymphotoxin-b receptor signaling is critical for lymph node and high endothelial venule formation. J. Exp. Med. 210, 465-473 (2013).
50. Rosen, S. D. Ligands for L-selectin: homing, inflammation, and beyond. Annu. Rev. Immunol. 22, 129-156 (2004).
51. Hemmerich, S. et al. Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes. Immunity 15, 237-247 (2001).
52. Uchimura, K. et al. N-acetylglucosamine 6-O-sulfotransferase-1 regulates expression of L-selectin ligands and lymphocyte homing. J. Biol. Chem.. 279, 35001-35008 (2004).
53. Kawashima, H. et al. N-acetylglucosamine-6-O-sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules. Nat. Immunol. 6, 1096-1104 (2005).
54. Uchimura, K. et al. A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules. Nat. Immunol. 6, 1105-1113 (2005).
55. Ngo, V. N. et al. Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189, 403-412 (1999).
56. Dejardin, E. et al. The lymphotoxin-b receptor induces different patterns of gene expression via two NF-kB pathways. Immunity 17, 525-535 (2002).
57. Hjelmström, P. et al. Lymphoid tissue homing chemokines are expressed in chronic inflammation. Am. J. Pathol. 156, 1133-1138 (2000).
58. Mueller, S. N. et al. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317, 670-674 (2007).
59. Baekkevold, E. S. et al. The CCR7 ligand ELC (CCL19) Is transcytosed in high endothelial venules and mediates T cell recruitment. J. Exp. Med. 193, 1105-1112 (2001).
60. Berahovich, R. D., Lai, N. L., Wei, Z., Lanier, L. L. & Schall, T. J. Evidence for NK cell subsets based on chemokine receptor expression. J. Immunol. 177, 7833-7840 (2006).
61. Lanier, L. L. NK cell recognition. Annu. Rev. Immunol. 23, 225-274 (2005).
62. Sigmundsdottir, H. & Butcher, E. C. Environmental cues, dendritic cells and the programming of tissue-selective lymphocyte trafficking. Nat. Immunol. 9, 981-987 (2008).
63. Schreiber, R. D., Hicks, L. J., Celada, A., Buchmeier, N. A. & Gray, P. W. Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. J. Immunol. 134, 1609-1618 (1985).